The diabetes prevention and reversal potential of these medications may ultimately prove more significant than their weight loss effects
Until recently, therapeutic strategies for people with obesity were of limited efficacy 2 , with the main strategies for weight loss focused on lifestyle interventions, including diet and exercise 3
Early medication intervention is safe and effective : Adding phentermine at 1 month showed no serious adverse events, with 53.9% of early non-responders achieving clinically meaningful 5% weight loss compared to just 25.3% on placebo
Theoretically, it could restore a healthy balance to the microbiome, which could, in turn, help people maintain a healthy weight
Youre getting specialist-level care at general practitioner prices
(We use semaglutide 2.4 mg to describe the drug marketed as Wegovy independent of dose to distinguish it from other brands of semaglutide-containing products [i.e., Ozempic, Rybelsus] that have different indications and/or routes of administration.) Clinical trials in the Semaglutide Treatment Effect in People with Obesity (STEP) program have demonstrated the efficacy of semaglutide 2.4 mg in reducing weight in adults with obesity and overweight [9]